Original Article
Copyright ©2013 Baishideng.
World J Otorhinolaryngol. Aug 28, 2013; 3(3): 100-107
Published online Aug 28, 2013. doi: 10.5319/wjo.v3.i3.100
Figure 1
Figure 1 Study design. Cisplatin injections (1 mg/kg ip) were given twice daily in two cycles separated by 10 d of rest, and adenosine amine congener (ADAC) (100 μg/kg ip) was administered as five daily injections at 24 h intervals. ADAC treatment was administered along with the second cisplatin cycle (Regime 1) or immediately after completion of both cycles (Regime 2).